// App-Quantinova.ai

2547 : Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Researchers

Presenter

  • Greg Malnassy

Principal Investigators

  • Susan Geyer

  • Noreen Fulton

  • Richard M. Stone

  • Bruce D. Cheson

  • Malek Faham

  • Wendy Stock

  • Greg Koval

  • Donna Niedzwiecki

  • Victoria Carlton

  • Li Weng

  • Lawrence D. Kaplan

  • Guido Marcucci

  • Lloyd E Damon

  • Richard A. Larson

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Hematology/Oncology and Comprehensive Cancer Center, University of Chicago, Chicago, IL

  • Alliance Statistics and Data Center, The Ohio State University, Columbus, OH

  • The Ohio State Univerisity, Columbus, OH

  • The University of Chicago Medical Center, Chicago, IL

  • Alliance for Clinical Trials in Oncology, Boston, MA

  • Alliance for Clinical Trials in Oncology, Boston, MA

Locations

  • United States

Companies

  • Sequenta, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mantle cell lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • T cell receptor beta locus

  • T cell receptor delta locus

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved